Azvudine, an oral drug for the new crown, is now available for online sale

25/12/2022
Fosun Pharma, the exclusive commercialization partner of the domestic new crown oral drug Azvudine, confirmed that Azvudine has been opened for online sales. Azvudine will first implement online prescriptions and issue prescriptions on the Fangzhou Jianke APP and Jingdong Health Fever Clinic It is also necessary to have a positive nucleic acid test or a positive antigen test as evidence, and the price is 330 yuan/bottle (1mg*35 tablets). In an interview with the media, Professor Chang Junbiao, the inventor of Azvudine and vice president of Zhengzhou University, said that Azvudine, as a nucleoside analog that inhibits viral RNA-dependent RNA polymerase (RdRp), can specifically act on The RdRp of the new coronavirus can inhibit virus replication, and its drug is highly targeted and long-acting. | Related reading (Financial Association)

Li Quanlin

In November of this year, Azivudine was briefly sold online at Neptunus drugstores on platforms such as Ele.me and Meituan, but was suddenly stopped later. Because this is a prescription drug, its use has strict conditions. Moreover, it is mainly aimed at severely ill patients with new crowns.

This time, it is not very appropriate to issue prescriptions and sell them through online diagnosis and treatment. How this online consultation platform can ensure that patients need to take this drug, and whether it will lead to the abuse of such drugs, is actually very difficult to control.

Personally, I often buy prescription drugs on online platforms. Basically, online pharmacists and doctors turn a blind eye and turn a blind eye. However, some psychiatric drugs cannot be obtained through online clinics, and must be obtained in hospitals. Even the online clinics opened by some hospitals do not prescribe some controlled drugs.

Azvudine was originally used for AIDS, and the treatment of new coronary pneumonia is just another function of it. Whether such a large-scale relaxation of control will lead to abuse needs to be carefully evaluated.

This article is reproduced from: https://www.fortunechina.com/jingxuan/25560.htm
This site is only for collection, and the copyright belongs to the original author.